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Introduction
Lung transplantation is a treatment option for
patients with end-stage lung disease. Between
1991 and 2002, 591 single and double lung trans-
plantations were performed in Italy. One- and 5-
year survival is reported to be 61% and 41% re-
spectively for single or double lung and heart and
lung transplantation in the Italian Lung Transplant
Registry. With the improvement in survival rates,
concern has arisen about how to assess quality of
life (QoL) in these patients. Over the last few years
the assessment of health-related QoL after lung
transplantation has been included as a measure of
patient outcomes, together with survival and rates
of complications [1, 2]. QoL after lung transplan-
tation has been measured by various question-
naires and dramatic improvements have been ob-
served [3-5]. Several factors and their association
with QoL have been evaluated in turn and include
age, gender, education, length of time since trans-
plant, presence of bronchiolitis obliterans syn-
drome (BOS), pulmonary diagnosis and psychic
conditions [6-10].
The aim of the study was to describe health-re-
lated QoL measured by generic and disease- spe-
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ABSTRACT: Determinants of quality of life after lung
transplant: an Italian collaborative study. S. Ricotti, 
P. Vitulo, L. Petrucci, T. Oggionni, C. Klersy for the Italian
Group on QoL in Lung Transplant.
Background. With the improvement in survival rates
after lung transplantation, concern has arisen about eval-
uating quality of life (QoL). This multicenter cross-sec-
tional study aimed at describing QoL and identifying fac-
tors associated with it.
Methods. We assessed QoL in 129 lung transplant re-
cipients from 5 centres in Italy, during scheduled follow-
up visits, using the SF-36, GHQ and St George’s respira-
tory questionnaires (SGRQ).
Results. The SF-36 elicited impaired QoL in the phys-
ical, but not in the mental domains (PCS=44; MCS=53).
The GHQ identified 29 patients (23%) with psychological
discomfort and the SGRQ scores were significantly better
than those of patients with chronic respiratory disease. On
multivariate analysis, exertional dyspnea was an indepen-
dent predictor of the PCS (adjusted ∆ -6.3 (p<0.001), while
osteoporosis (∆=-3.1), BOS (∆=-4.3), acute rejection 
(∆=-3.9) and heart and lung transplant (∆=+6.4) were on-
ly marginally associated. Dyspnea was also related to a
GHQ score >5.
Conclusions. The study identified exertional dyspnea
as the main determinant of QoL as measured both by
SF36 (PCS) and GHQ. Other objective measures con-
tributed only to the PCS. Thus, the SF-36 (PCS) and GHQ
were useful in identifying patients who needed treatment
not only for complications but also psychological support
and continued physical rehabilitation.
Monaldi Arch Chest Dis 2006; 65: 1, 5-12.
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cific questionnaires in a large population of lung
transplant recipients from different Italian centres.
It also aimed to identify factors associated with an
impaired QoL by assessing several aspects of pa-
tients’ characteristics, in order to highlight areas
requiring medical/psychological intervention. In
particular, we assessed the relationship between
QoL and disease-specific symptoms or treatment-
related side effects, as well as other demographic
and functional characteristics of the patients.
Material and methods
Study Design
This was a multicentre cross-sectional obser-
vational study.
Patients
129 lung transplant recipients, from five cen-
tres in Italy, participated in the project. They at-
tended scheduled follow-up visits between Febru-
ary 2001 and February 2002 at the pneumologic
outpatient clinics of the participating centres, three
or more months after transplant. More than 60% of
the patients were enrolled in one centre, while 83%
were enrolled in 2 centres. The project was ap-
proved by the Ethical Review Board of the refer-
ence centre.
Clinical assessments
During these visits each patient underwent a
complete clinical assessment by both a pneumolo-
gist and a physiatrist. This included a personal in-
terview in which patients were asked whether they
had returned to work or resumed sporting activi-
ties, as well as questions about their level of au-
tonomy, the presence of symptoms and signs, as
listed in table 1. A physical examination was also
carried out and respiratory function was measured.
Pre-transplant data was retrieved from clinical
charts or directly from the patient. Respiratory
function was evaluated by the 6-minute walking
test (6MWT) [11, 12]. The degree of dyspnea was
measured both on a visual analogic scale (VAS)
and on the Borg scale before and after the 6MWT
[12]. Forced expiratory volume in 1 second
(FEV1) and oxygen arterial pressure (PaO2) were
measured according to standard procedures [13].
The occurrence of severe infection, acute rejection
and the presence of bronchiolitis obliterans syn-
drome (BOS) and of osteoporosis in the previous
month was also assessed. Infection and acute and
chronic rejection were diagnosed according to cur-
rent international guidelines [14-16]. Osteoporosis
was diagnosed clinically and/or by means of bone
mineral density measurements [17, 18]. Question-
naires to investigate the patients’ health-related
QoL were handed out for self-completion and
were collected at the end of the visit. No time lim-
it or specific order was set for the completion of
the questionnaire.
Health- related quality of life
Three different instruments were used to in-
vestigate generic (SF-36 and GHQ) and disease-
specific (SGRQ) aspects of QoL. All of them were
translated and validated for use in the Italian pop-
ulation [19-21].
The MOS 36-Item Short-Form Health Survey
(SF-36) is an internationally-validated instrument
for generic health surveys. Eight domains are ex-
plored: physical functioning (PF); role limitations
due to physical problems (RP); bodily pain (BP);
general health (GH); vitality (VT); social function-
ing (SF); role limitations due to emotional prob-
lems (RE), and mental health (MH). The SF-36 al-
so measures changes in health status over time.
The questionnaires were scored in accordance with
the SF-36 Manual [22]. Finally, we computed
norm-based physical (PCS) and mental (MCS)
component summaries that aggregate information
regarding the mental and physical components
from the 8 domains [23]. Norm-based scores were
calculated for the eight domains and the aggregate
measures, based on the 1998 healthy Italian popu-
lation [19] to allow a direct comparison between
the 8 domains and the normal reference popula-
tion. All scores above or below 50 are above or be-
low the average, respectively, compared to the
healthy Italian Reference Population. Higher
scores correspond to a better QoL.
The General Health Questionnaire (GHQ-30
items) is a recognised instrument for detecting cur-
rent non-psychotic disorders and has been widely
used to detect minor psychiatric disorders [24]. For
each item, the respondent is asked to compare his
recent health status with his usual status and an item
is scored as being present only if it is being experi-
enced ‘more (less) than usual’. Scores range from 0
to 30; the lower the score, the better the QoL. A
threshold of between 5 and 6 was used in the present
study to identify patients with psychiatric disorders,
in order to reach a higher specificity than that ob-
tained with the usual cut-off between 4 and 5 [25].
The St. George’s Respiratory Questionnaire
(SGRQ) is a standardised self-administered air-
ways disease-specific questionnaire divided into 3
subscales [26]: symptoms (8 items), activity (16
items) and impact (26 items). These questionnaires
were scored according to the Manual for the Ital-
ian Version [21]. Scores range from 0 (no impair-
ment) to 100 (maximum impairment). No healthy
group-based norms are available for the general
Italian population.
Statistical Analysis
Descriptive statistics were reported as mean
and standard deviation (SD), or median and in-
terquartile range (IQR), for continuous variables,
and as absolute and relative (%) frequencies for
categorical variables. Mean and 95% confidence
intervals (95%CI) were also computed for the SF-
36 and SGRQ scores. The SF-36 norm-based
scores were also compared against the average val-
ue of the Italian population, and the SGRQ scores
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Table 1. - Socio-demographic, clinical and functional characteristics (For abbreviations, see text)
Characteristic Description
Age-years (mean (SD)) 47.9 (13.0)
≤ 50 years 58 (45%)
Male 84 (65%)
BMI Pre Tx (mean (SD)) 22.7 (4.1)
Post Tx (mean (SD)) 22.6 (4.4)
Diagnosis Emphysema 32 (25%)
Pulm. Fibrosis 42 (33%)
Cystic Fibrosis 29 (23%)
Pulm. hypertension 16 (12%)
Other 9 (7%)
Transplant Single Lung 63 (49%)
Double lung 59 (45%)
Heart &Lung 8 (6%)
Months since transplant (median (IQR)) 27 (9-51)
Return to work 34 (26%)
After occupation suspended due to lung disease 26 (30%)
Return to sport 28 (22%)
After sport suspended due to lung disease 17 (39%)
Independence Going out alone 104 (81%)
Going out accompanied 15 (12%)
Going upstairs 116 (90%)
Driving 88 (68%)
Cycling 42 (33%)
Symptoms Tremors 55 (43%)
Paresthesias 36 (28%)
Tiredness 29 (22%)
Exertional Dyspnea 50 (39%)
Cough 29 (22%)
Secretions (mucus) 19 (15%)
Pain (joints/muscles) 48 (37%)
Osteoporosis 32 (25%)
FEV1 l (mean (SD)) 2.23 (1.02)
PaO2 mm Hg (mean (SD)) 84 (12)
6MWT meters (median (IQR)) 560 (400-630)
VAS Pre-6MWT (median (IQR)) 0.5 (0.0-2.0)
Post-6MWT (median (IQR)) 2.7 (1.1-5.0)
Borg scale Pre-6MWT 0.5 (0.0-1.5)
Post-6MWT 3.0 (1.0-4.0)
Major infections (current or in the previous months) 26 (20%)
Acute rejection (current or in the previous months) 13 (10%)
BOS 18 (14%)
Grade I-II 11 (61%)
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were compared against the average values of the
validating population with chronic respiratory dis-
ease, by means of one-sample t-test. The Kruskall
Wallis test was used to compare scores from QoL
questionnaires (SF-36 and SGRQ) across risk
groups, as defined below. The Fisher exact test was
used to compare GHQ categories. Risk groups
were defined according to age, gender, pneumolog-
ic diagnosis, type of transplant, time from trans-
plant, concomitant or recent major infection, acute
and chronic rejection, osteoporosis, presence of
pain and respiratory function. For study purposes,
the 6MWT, FEV1 and time from transplant were
categorised according to the tertiles of their distrib-
ution and age according to its median distribution.
A multivariate general linear regression model was
fitted to identify independent determinants of the
physical component summary (PCS) of SF-36. Af-
ter assessing for collinearity, variables with a p-val-
ue <0.2 on univariate analysis were considered.
Stata 8 (StataCorp, College Station, TX) was
used for computation. A 2-sided p-value <0.05
was considered statistically significant. The results
of tests on QoL are reported without correction for
multiple tests.
Results
Patients’ sociodemographic, clinical and func-
tional characteristics are summarised in table 1.
Half of the patients were assessed between 9 and 51
months after the transplant. The majority were
male; half of them were aged 50 or under. Body
mass index (BMI) was within normal ranges. Em-
physema, pulmonary fibrosis and cystic fibrosis
percentages were similar and accounted for 81% of
all native lung diagnoses, overall. Single and bilat-
eral lung grafts were evenly distributed. Only a
quarter of the entire study population was em-
ployed and/or practised a sport when QoL was as-
sessed. However, 30% of those patients who had
previously been employed had returned to work
and 40% had resumed sport. The vast majority had
achieved a satisfactory level of autonomy. A wide
percentage of patients (15 to 44%) reported symp-
toms and signs. Most of these were related to side
effects of treatment and included tremors, paresthe-
sias, muscle and joint pain and osteoporosis. Respi-
ratory function was fair. Most patients (84%) were
able to perform the 6MWT, with only 25% of them
walking less than 400 metres, with a minor increase
in the degree of dyspnea, as measured by the VAS
and Borg scales. Mean FEV1 was good and PaO2
was within normal ranges. A minority of patients
suffered from recent episodes of severe infection,
acute rejection and BOS (mainly grade I and II).
Health-related QoL. Patient co-operation was
high: all patients completed at least one question-
naire and 95% completed all three. Most norm-
based SF-36 scores were very close to 50, the aver-
age for the normal population. Compared to the ref-
erence population, QoL could be considered nor-
mal regarding BP and SF, and better than normal
with respect to VT and MH (p=0.003 and p<0.001,
respectively), but worse than average PF, RP and
GH (p<0.001 in all cases) (figure 1a). In the RP di-
mension, in particular, 25% of the patients had
norm-based scores below 28. Overall, a moderate
deterioration in QoL was elicited in the summary
measure for physical well-being, with a mean PCS
of 44.3 (95%CI 42.5-46.0), p<0.001, while mental
well-being was even above the average for the nor-
mal population, with a mean MCS of 52.6 (95%CI
51.0-54.2), p<0.001. Health was rated as better or
much better compared to one year earlier by 62%
of patients and worse by only 10%. The GHQ ques-
tionnaire highlighted good results in the psychic di-
mensions, with a low median score of 2 (IQR 0-5),
although 29 patients (23%) were identified as hav-
ing signs of psychological discomfort (score >5)
and 35 (28%) had a score >4. Scores calculated
from the SGRQ are illustrated in figure 1b; they
were well below values measured in the Italian val-
idation cohort of patients with chronic respiratory
disease, reported to be 54.4 (SD 19.2), 43.3 (SD
24.3), 71.1 (SD 19.0) and 48.6 (SD 22.0) overall,
for symptoms, activity and impact, respectively
(p<0.001 in all cases) [21].
The association between QoL and clinical
characteristics for subjective and objective mea-
sures (SF-36 and GHQ) is reported in table 2. The
PCS measure of QoL was significantly worse in-
patients over 50, in those with osteoporosis, exer-
tional dyspnea and in patients who had experi-
enced acute rejection in the last few months. It was
marginally worse in patients who had undergone
single lung transplantation and in patients with
joint or muscle pain. On multivariate analysis
(model p<0.0001, R2=0.28), exertional dyspnea
was the only independent determinant of PCS,
with an adjusted decrease in the QoL score of –6.3
(95%CI –9.8 to –2.9, p<0.001). Osteoporosis,
BOS and acute rejection were marginally associat-
ed with a decreased QoL and heart and lung trans-
plant with an increased QoL (compared to double
lung transplant): adjusted differences and confi-
dence intervals pointed to an association of these
characteristics and patients’ well-being and were
–3.1 (95%CI –6.8 to 0.6, p=0.102) for osteoporo-
sis, -4.3 (95%CI –8.9 to 0.4, p=0.072) for BOS, -
3.9 (95%CI –9.2 to 1.5, p=0.154) for acute rejec-
tion and 6.4 (95%CI –0.4 to 13.2, p=0.063) for
heart and lung vs. double lung transplant. Interest-
ingly, no time effect was apparent.
On the contrary, the MCS score did not differ
between the categories of risk groups, although,
surprisingly, patients with BOS tended to perform
better.
Only exertional dyspnea was associated with
psychological discomfort with a GHQ score >5
and was more frequent in patients with an im-
paired GHQ. A marginal association was observed
for osteoporosis. Also here the length of time since
transplant did not influence the level of QoL.
Similarly, when considering SGRQ scores, no
group appeared to perform worse, although we did
observe some variability between the categories of
patients.
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No centre effect was elicited in any of the di-
mensions explored by the three questionnaires.
Discussion
An assessment of the general health of 129
lung or heart and lung transplant recipients at a
median of 27 months after surgery highlighted an
overall fair quality of life, as measured by the three
questionnaires, as well as good levels of autonomy
and normalization of functional indices (FEV1,
paO2 and distance covered during the 6MWT).
Our patients were evaluated during scheduled fol-
low-up visits, three or more months after the trans-
plant, and thus were clinically stable. Major infec-
tions and acute rejection were observed in a mi-
Fig. 1. - Health related QoL evaluated by the SF-36 (panel a) and SGRQ (panel b). Mean (squares) and 95% CI (segments) are reported for each
domain in the two questionnaires. The horizontal line in panel “a” corresponds to the norm for the Italian population. (For abbreviations see text).
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Table 2. - Association of clinical characteristics and QoL: Generic questionnaires (SF-36 & GHQ)
SF-36 GHQ
Characteristic PCS1 p-value MCS1 p-value Impaired (GHQ>5) p-value
Age ≤50 yrs 48 (42-54) 54 (45-59) 11 (19%)
0.015 0.332 0.396
>50 yrs 41 (35-51) 54 (48-60) 18 (24%)
Gender F 46 (36-54) 54 (49-58) 10 (24%)
0.508 0.939 1.000
M 45 (37-51) 54 (47-60) 19 (23%)
Diagnosis emphysema 47 (38-54) 53 (49-58) 8 (26%)
pulm fibrosis 42 (35-52) 52 (46-60) 10 (24%)
cystic fibrosis 49 (42-52) 0.335 54 (47-59) 0.766 6 (21%) 0.703
pulm hypert 45 (38-49) 58 (45-60) 2 (12%)
other 40 (25-57) 58 (54-62) 2 (25%)
Type of TX single lung 44 (35-50) 53 (47-60) 14 (23%)
double lung 47 (40-53) 0.052 54 (47-60) 0.707 12 (21%) 0.892
heart & lung 51 (45-56) 58 (51-60) 2 (25%)
Time since TX ≤18 months 45 (37-50) 51 (46-57) 9 (22%)
18-41 months 47 (40-54) 0.316 54 (46-60) 0.116 9 (21%) 1.000
>41 months 46 (35-52) 56 (49-61) 10 (23%)
6MWT ≤490 m 46 (37-51) 53 (47-59) 11 (23%)
491-629 m 52 (47-59) 0.521 53 (48-58) 0.468 7 (32%) 0.092
≥630 m 53 (48-61) 57 (51-60) 3 (9%)
Exertional dyspnea no 49 (41-54) 54 (49-60) 34 (36%)
<0.001 0.949 0.030
yes 40 (31-47) 54 (45-60) 17 (61%)
Osteoporosis no 47 (39-53) 55 (48-57) 18 (19%)
0.008 0.317 0.089
yes 40 (31-49) 52 (43-60) 11 (34%)
BOS no 46 (38-52) 53 (47-59) 26 (54%) 0.762
0.119 0.082
yes 40 (29-49) 58 (55-62) 3 (17%)
Acute rejection no 46 (37-53) 54 (47-60) 24 (21%)
0.030 0.522 0.171
yes 41 (29-45) 50 (47-60) 5 (38%)
Severe infection no 46 (38-53) 53 (47-59) 21 (21%)
0.137 0.357 0.301
yes 43 (36-49) 57 (45-61) 8 (31%)
FEV1 ≤2.14 46 (31-52) 56 (49-60) 11 (27%)
2.15-3.05 45 (35-49) 0.116 51 (45-59) 0.354 7 (18%) 0.628
>3.05 50 (40-54) 54 (48-60) 9 (24%)
Pain (joints, muscles) no 47 (40-53) 53 (47-59) 17 (21%)
0.053 0.295 0.668
yes 42 (35-49) 56 (48-60) 12 (25%)
Centre Pavia 43 (36-52) 52 (47-60) 19 (23%)
0.151 0.847 1.000
Others 46 (40-53) 53 (47-60) 10 (22%)
1 Median (IQR); abbreviations: see text.
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nority of patients (10-20%). Only 18 patients had
signs of BOS; 61% of them being BOS grade I-II.
The SF-36 questionnaire elicited some impair-
ment in the physical domain while the mental do-
main, showed an increase compared to the normal
Italian population, as expected after a successful
transplant. This coincides with the findings of Pin-
son et al [1] who report a PCS of 36 and an MCS of
53 and those of Stavem et al (PCS=41 and MCS=57)
[3]. However, scores for the single dimensions cal-
culated in our study were lower than those reported
by Limbos [7], as regards PF, RP and GH in partic-
ular. This author did not find substantial differences
between the physical and mental dimensions after
transplantation. The clinical characteristics of his
transplant recipients were similar to those of our pa-
tients, except for a higher prevalence (48%) of pa-
tients with an original diagnosis of emphysema. On
the contrary, our scores were higher than those
recorded by Hummel [5], although he did not pro-
vide any information on functional assessment in
these patients for a meaningful comparison. In ac-
cordance with the MCS evaluation in our popula-
tion, the GHQ questionnaire gave good results in the
psychic dimension. In addition, it allowed us to iden-
tify a minority of patients with signs of psychologi-
cal discomfort who required further investigation:
23% of our patients scored >5 and 28% >4. To our
knowledge, no studies have been carried out in lung
transplant patients using the GHQ. Triffaux reported
higher figures after heart transplantation; 37% of his
patients evaluated between 1 to 41 months after
transplant had a GHQ score >4 [27]. The SGRQ
scores in our population were significantly better
than those in the Italian validating series with chron-
ic respiratory disease [21]. An informal comparison
with published scores measured in the healthy Span-
ish population showed values close to the upper lim-
it (95th percentile) [28]. Scores in the activity and
impact areas were comparable with those published
by Stavem [3] in a population with lower mean
FEV1 (1.6 l), although our patients showed better
scores in the symptoms area (24 vs. 43).
Age (>50 years), exertional dyspnea, osteo-
porosis and acute rejection in the previous month
were definitely associated with an impaired QoL
in the PCS of the SF-36 on univariate analysis, al-
though single lung transplant and joint or muscle
pain were also marginally involved in determining
a lower score. On multivariate analysis, the pres-
ence of exertional dyspnea was the major determi-
nant of PCS, although the role of osteoporosis,
BOS, acute rejection and type of transplant (heart
and lung particularly) should not be ignored. On
the contrary, time since transplant and underlying
diagnosis were not found to be associated with
QoL in our sample. Exertional dyspnea in our case
series also allowed us to identify patients with psy-
chological discomfort (GHQ>5); similarly, osteo-
porosis was more frequent in these patients, al-
though not significantly. No determinants of QoL
as measured by the MCS of the SF-36 and SGRQ
were elicited in our case series.
Others have also explored some of these risk
factors and our results are in line with the existing
literature, although the use of different instruments
makes it difficult to draw comparisons. The vari-
ous authors have identified (with formal statistical
comparisons or informally) BOS, age, type of
transplant, comorbidities and complications as be-
ing associated with QoL impairment in the physi-
cal dimension [2, 4, 6, 10], while no relationship
has generally been reported with the length of time
since transplant during a follow-up comparable to
ours [3, 4], with the exception of McNaughton [8]
who reported an association of time since trans-
plant and the mental but not the physical dimen-
sion of SF-36. Our data is also consistent with a
case series of heart transplant patients who were
followed-up at the same co-ordinating centre for at
least 10 years [29].
This evaluation of mid-longterm transplant pa-
tients from different centres gives a picture of the
situation in Italy 10 years after the lung transplan-
tation program started. We assessed QoL using
standardised instruments validated in Italy. Com-
pared to other case series [1, 3, 6, 7], it covered a
large population, over a wide time span, with 50%
of our patients having undergone a transplant op-
eration over two years earlier, and 25% more than
four years earlier. The evaluation of QoL was well
accepted, with a compliance of 95% for the three
questionnaires. QoL was also correlated, by means
of a multivariate analysis, to symptoms and signs,
including those related to treatment side effects,
respiratory function and levels of autonomy in a
comprehensive assessment of patients’ character-
istics, while most of the published literature has
considered only a few of them at a time [6, 8-10].
The study identified exertional dyspnea as the
main determinant of QoL as measured by both
SF36 (PCS) and GHQ. Other objective measures
contributed only to the PCS.
The main limit of the study was its cross-sec-
tional design, which did not allow us to gauge the
actual improvement in QoL after lung transplanta-
tion, nor how it changed over time in each patient.
In this case series, time since transplant did not
elicit different values of QoL scores between the
groups of patients. However, the study was able to
answer the stated aims of identifying risk factors
for a deteriorated QoL.
Lung and lung and heart transplant recipients
evaluated at midterm after transplantation showed
a fair to good health-related QoL as measured by
three standardised instruments, more in the mental
than in the physical dimension. The disease-spe-
cific questionnaire (SGRQ) we used was not able
to discriminate between patients. This was not un-
expected, given that it was developed for chronic
respiratory disease, whereas few patients in our
case series showed signs of BOS. On the other
hand, the generic SF-36 and GHQ questionnaires,
were sensitive towards patients’ symptoms and
functioning and easy to administer, and so may be
useful in identifying subgroups of patients who
need treatment not only for complications such as
infections, acute rejection or BOS, but who should
also receive psychological support and continued
physical rehabilitation.
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